SEC Form 4 · accession 0001401225-15-000005
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Baljinder Bhullar
Officer — CFO · Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 16, 2015 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Dec 16, 2015 | A | 14,125 | — | A | 155,375 | D | |
| Common Shares | holding | — | — | — | 141,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $0.32 | Jul 11, 2011 | A | 10,000 | A | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 10,000 | 110,000 | D |
| Stock OptionsF1,F2 | $0.09 | Jun 18, 2013 | A | 17,500 | A | Jun 18, 2013 | Jun 18, 2018 | Common Shares | 17,500 | 302,500 | D |
| Stock OptionsF1,F2 | $0.10 | Dec 23, 2014 | A | 50,000 | A | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 50,000 | 852,500 | D |
| Stock OptionsF2 | $0.32 | holding | — | — | — | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 100,000 | 100,000 | D |
| Stock OptionsF2 | $0.09 | holding | — | — | — | Jun 18, 2013 | Jun 18, 2018 | Common Shares | 175,000 | 185,000 | D |
| Stock OptionsF2 | $0.10 | holding | — | — | — | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 500,000 | 802,500 | D |
Explanation of responses
- F1Adjusted to forward 1.1 split
- F2Adjusted price to Forward 1.1 split